Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Mutch

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 6, 2023
Response: FIGO staging of endometrial cancer 2023Nicole Concin, Xavier Matias-Guiu, Christina Fotopoulou, et al.
Gynecologic Oncology|February 16, 2016
Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapyAnupama Chundury, Anthony Apicelli, Todd DeWees, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 20, 2023
FIGO staging of endometrial cancer: 2023Jonathan S Berek, Xavier Matias-Guiu, Carien Creutzberg, et al.
Journal of Gynecologic Oncology|August 18, 2023
FIGO staging of endometrial cancer: 2023Jonathan S Berek, Xavier Matias-Guiu, Carien Creutzberg, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Gynecologic Oncology|December 18, 2019
Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group StudyLauren Krill, Wei Deng, Ramez Eskander, et al.
Gynecologic Oncology|February 26, 2018
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting reportStephanie Lheureux, Carolyn McCourt, B J Rimel, et al.
Gynecologic Oncology|November 21, 2025
AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancerJo'an Tankou, Sofia Ruau, Anjali Walia, et al.
Gynecologic Oncology|December 21, 2010
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q)Thomas J Herzog, Michael W Sill, Joan L Walker, et al.
Gynecologic Oncology|April 4, 2022
The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignanciesJoshua P Schiff, Mustafaa Mahmood, Yi Huang, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 6, 2023
Response: FIGO staging of endometrial cancer 2023Nicole Concin, Xavier Matias-Guiu, Christina Fotopoulou, et al.
Gynecologic Oncology|February 16, 2016
Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapyAnupama Chundury, Anthony Apicelli, Todd DeWees, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 20, 2023
FIGO staging of endometrial cancer: 2023Jonathan S Berek, Xavier Matias-Guiu, Carien Creutzberg, et al.
Journal of Gynecologic Oncology|August 18, 2023
FIGO staging of endometrial cancer: 2023Jonathan S Berek, Xavier Matias-Guiu, Carien Creutzberg, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Gynecologic Oncology|December 18, 2019
Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group StudyLauren Krill, Wei Deng, Ramez Eskander, et al.
Gynecologic Oncology|February 26, 2018
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting reportStephanie Lheureux, Carolyn McCourt, B J Rimel, et al.
Gynecologic Oncology|November 21, 2025
AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancerJo'an Tankou, Sofia Ruau, Anjali Walia, et al.
Gynecologic Oncology|December 21, 2010
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q)Thomas J Herzog, Michael W Sill, Joan L Walker, et al.
Gynecologic Oncology|April 4, 2022
The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignanciesJoshua P Schiff, Mustafaa Mahmood, Yi Huang, et al.
Pageof 9